StageZero Life Sciences Ltd
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a multi-cancer panel test for simultaneously screening for various cancers from a single sample of blood with high sensitivity and specificity for each cancer. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; COVID polymerase chain reaction testing and blood test analysis; Prostate Health Index, a screening test for prostate cancer; and BreastSentry, a test to determine a woman's risk for developing breast cancer. The company was founded in 1998 and is headquartered in Richmond Hill, Canada. Show More...
-
Sector Healthcare
-
Industry Diagnostics & Research
-
Last Quote 0.04 CAD
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.39 -0.28 -0.28 -0.29 -0.16 -0.11 -0.09 -0.03 -0.02 -0.02 -0.02 Dividends USD Payout Ratio % * Shares Mil 12.0 15.0 18.0 34.0 47.0 53.0 66.0 97.0 137.0 212.0 212.0 Book Value Per Share * CAD 0.010 0.05 0.15 -0.03 0.09 -0.11 -0.04 -0.05 -0.02 -0.02 Free Cash Flow Per Share * CAD -0.2 -0.27 -0.22 -0.15 -0.08 -0.04 -0.06 -0.07 -0.03 -0.03 Return on Assets % -84.8 -96.8 -71.99 -135.57 -223.19 -343.56 -294.52 -96.08 -152.3 -156.47 -156.47 Financial Leverage (Average) 56.97 1.98 1.72 1.36 Return on Equity % -373.5 -213.92 -259.32 -339.25 Return on Invested Capital % -92.05 -69.4 -203.25 -339.38 -394.88 Interest Coverage -7.2 -5.53 -6.11 -6.18 -135.53 -16.31 -12.05 -2.49 -3.33 -3.33 Current Ratio 2.66 3.15 8.27 2.37 3.76 0.24 0.1 0.1 0.06 0.05 0.05 Quick Ratio 1.94 2.43 8.12 2.33 3.68 0.23 0.05 0.03 0.03 0.02 0.02 Debt/Equity 43.17 0.76